HAPLOIDEMBRYOGENESE

European patent · EP3571926 · In force

Register entry

Publication number
EP3571926
Application number
EP19186241
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 24, 2014
Published
Nov 27, 2019
Granted
Mar 13, 2024
Protection ends at the latest
Sep 23, 2034
Next annual fee due
Sep 30, 2027
IPC classes
A01H 1/08 (2006.01)
A01H 1/00 (2006.01)
Priority
WO PCT/EP2013/069851 24.09.2013
Divided from
EP14772335
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Jan 22, 2025

    Change

    Published in Swissreg on 22.01.2025

  4. Oct 15, 2024

    Next annual fee due on

    Next annual fee due on
    30.09.2024 → 30.09.2025

    Published in Swissreg on 15.10.2024

  5. Mar 15, 2024

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 15.03.2024

  6. Mar 13, 2024

    Granted

    Published in Swissreg on 13.03.2024

Parties

Holder

Stichting Wageningen Research

Droevendaalsesteeg 4, 6708 PB Wageningen, NL

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

ANGENENT, Gerrit Cornelis

6704 AW Wageningen, NL

SORIANO CASTAN, Mercedes

22400 Monzon, ES

HUI, Li

Haidian District, Beijing 100094, CN

BOUTILIER, Kimberly

3453 ML De Meern, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.